Podcasts about churchill hospital

Varada Sethu joined Woman's Hour to talk about stepping into the iconic role of the Doctor Who companion. She tells Datshiane Navanagayam how she went from a guest star to landing the role of Belinda Chandra, why this character feels like her most personal yet, and what it means to her to bring cultural authenticity to the Tardis. With a background in science, classical dance, and Star Wars fandom, Varada brings a fresh energy to the Whoniverse.Grace Davidson was a teenager when she was diagnosed with a rare condition that meant she did not have a uterus. But, following a transplant using her sister's donated womb, she gave birth earlier this year to baby Amy. Nuala McGovern speaks to Isabel Quiroga, the surgeon who led the transplant team at the Churchill Hospital in Oxford, and to Lydia Brain, who is currently on the waiting list for a womb transplant.Emily MacGregor is a music historian and trombonist. After the sudden death of her father, a jazz guitarist, she found she wasn't able to bear the sound of music. The very thing that once connected them became a source of pain and silence. In her new book, While the Music Lasts, she explains how she reconnected with her father through the pieces left on his music stand, from tangos to Handel, Cádiz to Coltrane. She joined Nuala to talk about how she learnt to navigate grief and how she discovered the joy of music again.BBC2's Saving Lives in Cardiff is back on our screens from tonight. Based in the largest hospital in Wales, University Hospital in Cardiff, the series highlights the weight of difficult, sometimes life and death decisions surgeons make about who to prioritise next. The first episode follows Dr Indu Deglurkar, a cardiac surgeon, one of only 19 women in this role in the UK. She tells Nuala about the pressures and joys of her job.Have you been watching The White Lotus? The season three finale aired this week and one of the key themes that's had fans talking has been female friendship. It's left us wondering - is three a crowd? In the show the dynamic plays out between a trio of friends Jaclyn, Kate and Laurie, played by Michelle Monaghan, Leslie Bibb and Carrie Coon, who alternate between loving and loathing one another. So can friendships between three people work? TV critic Rachael Sigee and relationships writer at the Independent Olivia Petter joined Nuala McGovern.Presenter: Nuala McGovern Producer: Annette Wells Editor: Sarah Jane Griffiths

Grace Davidson was a teenager when she was diagnosed with a rare condition that meant she did not have a uterus. But, following a transplant using her sister's donated womb, she gave birth earlier this year to baby Amy. Nuala McGovern speaks to to Isabel Quiroga, the surgeon who led the transplant team at the Churchill Hospital in Oxford, and to Lydia Brain, who is currently on the waiting list for a womb transplant.A recent study into synthetic hair, which many black women use to achieve popular hair styles including braids, found that ten samples of the most well-used brands contained carcinogens, and in some cases, lead. It's provoked a big reaction online. Nuala McGovern is joined by academic and author of Don't Touch My Hair, Emma Dabiri, and also by BBC Correspondent Chelsea Coates.New play Shanghai Dolls explores the relationship between two of the most influential women in Chinese history during the cultural revolution; Jiang Qing (also known as Madame Mao – one of the architects of the Cultural Revolution) and Sun Weishi, China's first female director. Amy Ng the playwright and Gabby Wong who plays Madame Mao join Nuala in the Woman's Hour Studio.Set in a quiet 1950s seaside town in a boarding house full of strange characters, Jess Kidd's new novel Murder at Gull's Nest is the first in a new series of books. Jess talks to Nuala about the heroine of the series, the fearless former nun Nora Breen, who has left behind her enclosed order of nuns after 30 years to solve crimes.Presenter: Nuala McGovern Producer: Laura Northedge

For this special episode of the EMEA Recruitment podcast, to mark one year of our partnership with Operation Smile, we were joined by Dr. Lara Watson and Dr. Priya Chadha, surgical trainees in maxillofacial and plastic surgery respectively, Founders of Acquisition Aesthetics, and Business Ambassadors for Operation Smile.  “We agreed that our collective ambition was to try and support smiles.” Paul Toms spoke to Lara and Priya amongst their incredibly busy schedules. Lara, for instance, joined us from the Churchill Hospital in Oxford, the UK, where she treats patients with head and neck cancer. But it's our relationship with Operation Smile that connected Lara and Priya with Paul. Lara explains how both her and Priya's careers have paralleled each other's, due to their shared interests and ambitions. Around seven years ago, they set up Acquisition Aesthetics together, a training academy in aesthetics medicine. For them, it's the perfect balance between the function of science and the artistry of beauty.  Last year, Operation Smile reached out to them, highlighting the synergy between Lara and Priya's work in aesthetic medicine with the mission of the charity. Although aesthetics can often be confused with putting on a mask, Lara believes that deformity can take a person's sense of identity away from them, but she feels she gives back to the patient a face that they feel is theirs. They jumped at the opportunity to unite with Operation Smile, to raise awareness amongst healthcare professionals and their customers.  Lara quickly knew that surgery was the route for her. In head and neck surgery, she has found that the correction of deformity and restoration of function is limitless, and aesthetics is a “huge part of that”. She takes pride in her work and the impact it can have on someone's confidence; seeing a patient's response never gets boring. While it's a hugely rewarding career, Paul asks Priya to explain the business model of Acquisition Aesthetics. Their initial idea has bloomed into something that neither Lara nor Priya expected; they were recently awarded the Best Training Academy of the Year prize at the Aesthetics Awards 2021. But they're not businesspeople interested in the largest profits. In fact, their business model hasn't always worked financially.  However, providing a learning platform delivered by two surgeons is quite unique. It means that everyone going out with the Acquisition Aesthetics stamp is competent and confident in their work. Lara and Priya took their own learnings from being “left in the lurch” early in their careers with a desire to increase safety in the industry to create the business. Putting their educational material into practice was the most challenging part of the journey, but Lara and Priya brought in people with business backgrounds to support them. As surgeons, mothers and now businesspeople, Paul asks how Lara and Priya fit it all into their day. It's their support network that is a safety net for them, as well as recognising your limitations as human beings. They realised that they needed a team of invested people around them, who were also passionate about the cause.  It's taken years to get to this point, but Lara feels they've found balance and compromise in their relationship. Priya feels incredibly fortunate to share a strong working ethos and goals with Lara, and they've learnt a lot from each other along the way. Lara compares their relationship to a marriage, in which they require an unconditional commitment to each other. Their shared dream is what keeps everything spinning, she explains. But in a very male-dominated career, Lara and Priya have both faced difficulties. Lara is committed to understanding why women tend to undergrade themselves and what we can do to change it. Priya, too, wants to shout louder about the issues that still exist in society.  She is also passionate about her work in aesthetics and explains how tweaks to her own appearance have given her “immeasurable” confidence. Bringing the conversation back to the partnership with Operation Smile, Priya explains why the confidence Paul gained through his cleft surgery is personal to him. We end the episode on a jovial note, with Lara and Priya revealing the last thing that made them smile – Lara's was unfortunately too inappropriate for the podcast! Find out more about Lara and Priya's work on the Acquisition Aesthetics website: https://www.acquisitionaesthetics.co.uk/ You can also find them both on social media.  You can also find the EMEA Recruitment podcast on your podcatcher of choice, or via this link: If you're looking for a specific part of the episode, use the timestamps below:  01:05: Keeping busy in surgery02:04: A collective ambition to support smiles07:23: Why Lara chose head and neck surgery12:30: The business model of Acquisition Aesthetics22:00: Managing the hours in a day25:42: Finding synergy in their relationship30:07: What's in the pipeline?35:30: Advice for future female leaders41:54: Removing the barriers women are faced with45:08: Empowering people to use their emotions 48:20: Giving people the gift of confidence53:26: The last thing that made Lara and Priya smile56:04: How to reach out to them    We'd like to take this opportunity to thank Operation Smile for being the official partner of the EMEA Recruitment podcast for over one year! We're delighted to be able to raise awareness and funds for the work Operation Smile's volunteers do around the world. If you'd like to support Operation Smile, you can donate here: https://www.emearecruitment.com/operation-smile   The EMEA Recruitment podcast is hosted by Paul Toms, our Founder, and Rose Jinks, our Senior Marketing Executive. Find out more about EMEA Recruitment through our website: https://www.emearecruitment.com/ You can also find us on LinkedIn: https://www.linkedin.com/company/emea-recruitment-limited/ Connect with Paul on LinkedIn here: https://www.linkedin.com/in/paultoms/ Or follow him on Twitter: https://twitter.com/paul_toms    Do you have any suggestions for future podcast episodes? Let Rose know: rose.jinks@emearecruitment.com    #emearecruitment #emearecruitmentpodcast #larawatson #priyankachadha #healthcare #plasticsurgery #operationsmile

Derek Hockaday interviews Joe Smith, consultant urologist, 18 November 2013. Topics discussed include: (00:00:17) coming to Oxford, the adoption of pure urology across the country; (00:06:30) start of appointment in Oxford, 7 July 1966, other surgeon colleagues; (00:13:30) establishing urology as a separate subject; (00:14:34) the Churchill Hospital and Radcliffe Infirmary, junior surgeon duties; (00:18:45) Oxford standards compared to other places including University College Hospital, London and United States; (00:21:30) Boder Von Galtz; (00:22:40) micturating cystogram and spinning top urethra; (00:26:12) lecturing medical instruments sales staff about urology; (00:26:55) quality of nursing at Oxford and medical students; (00:29:01) operating theatres and Towler theatres; (00:31:53) Frank Ellis; (00:34:19) national meetings; (00:37:18) giving up general surgery; (00:41:16) interaction with various professors and giving up research sessions; (00:46:54) involvement in first transplantation of kidney; (00:49:08) president of various committees/unions; (00:51:00) development of the Oxford Medical School, 1966; (00:53:44) early childhood in Lancaster, choosing London over Manchester to train and post-qualification. Note the following sections of audio are redacted: 00:08:07-00:08:30; 00:11:26-00:11:34; 00:36:29-00:36:41; 00:43:54-00:44:05; 00:44:43-00:45:40 and 00:48:19-00:48:31.

Derek Hockaday interviews Neil Mortensen, consultant colorectal surgeon, 10 November 2014. Topics discussed include: (00:00:20) moving to Oxford from senior lecturer role in Bristol; (00:02:39) Sidney Truelove and gastroenterology surgery; (00:03:39) general surgery; (00:06:33) introduction of specialisation in Oxford medicine; (00:08:11) the effect of specialisation on undergraduate and clinical teaching; (00:10:06) the national matching scheme; (00:11.32) effect of imaging on examining patients, importance of physical signs; (00.13:04) rectal cancer and imaging; (00.14:00) nursing in Oxford compared to Bristol, anaesthetists; (00:16:35) anal rectal physiology; (00:19:03) intraluminal ultrasound; (00.19:59) development of colitis treatment; (00.22:13) the Association of Colorectal Surgeons; (00.23:39) introduction of national bowel cancer screening program; (00.25:16) change in junior staffing during Mortensen's career; (00.28:05) the Oxford Colon Cancer Trust; (00.31:15) assisting other surgeons with surgery; (00.33:12) time outside Oxford for meetings and commitments including director of general, vascular, trauma surgery and gastroenterology role; (00.37:35) rise of the managerial class and rise of the administrator in medicine; (00.43:12) three session lists in surgery at the Churchill Hospital; (00.44:21) post-operative care; (00.46:33) publications; (00.48:35) private practice; (00.51:27) moving gastrointestinal surgery to the Churchill site near to Oncology ward; (00.56:37) work with Walter Bodmer; (00.57:46) genetic analysis. Note the following section of audio is redacted: 00:00:00-00:00:05.

Derek Hockaday interviews consultant chest physician Donald Lane, 31 Oct 2013. Topics discussed include: (00:00:12) coming to Oxford; (00:04:20) Honor Smith; (00:07:37) Christchurch College; (00:09:02) clinical years at St. Barts. Hospital, London; (00:12:43) working in surgery, medicine and Accident and Emergency at Redhill Hospital; (00:14:54) returning to Oxford for post-registration house job; (00:16:45) senior house job in Manchester; (00:18:16) Douglas Black; (00:20:16) research Dphil; (00:24:29) returning to Oxford, registrar position; (00:26:27) Paul Beeson; (00:30:14) combining general medicine with respiratory medicine at the Chest Unit and Churchill Hospital; (00:35:10) changes at the Chest Unit in Lane's time; (00:38:22) work on asthma, importance of The Asthma Society; (00:45:40) stopping general medicine in 1980; (00:48:23) university work during consultancy; (00:50:46) national commitments; (00:51:54) role of Oxford education in medical career; (00:53:07) evolution of treatment of Cystic Fibrosis; (00:58:37) legacy of the Oxford hospital orchestra; (01:01:34) comparing standards of care between Oxford, Redhill and St. Barts.; (01:04:15) case presentations.

Join me as I delve into the realms of urology with Mr. Alastair Lamb, a Consultant Urologist at the Churchill Hospital in Oxford.

I was able to go back to the Churchill Hospital, Oxford, and speak to Carol Scott about her exceptional team in the Radiotherapy Department. It was incredible the level of service that I and many others have received there. I was keen to know how that was built and where it comes from. There were many messages in there that big businesses could learn from too.

Michael Seres, Founder & CEO, 11 Health Michael Seres, the Founder/ CEO of 11 Health and Technologies Limited, was diagnosed with the incurable bowel condition, Crohn's Disease at the age of 12. After over 20 operations and an intestinal failure, Michael became the 11th person to undergo a small bowel transplant at the Churchill Hospital in Oxford, UK, which included becoming a stoma patient. Additionally, Michael is also a 2-time Cancer patient. In 2013, Michael founded the health tech start up 11 health and has developed sensor technology for ostomy patients. Michael, started blogging about his journey through Bowel Transplant and his blog now has over 100,000 followers. He uses social media to develop global online peer to peer communities: covering over 20,000 patients. He is now the patient lead for the main UK health twitter chat #NHSSM, a member of the NHS England Digital Services user council, a published author and a professional speaker. He is the inaugural e-patient in residence and an executive board member at Stanford Medicine X. Michael helped implement the first skype clinics in Oxford Hospital and is an ambassador to the Doctors 2.0 conference.

Dr Clare Dollery describes a retained swab Never Event that happened in the Churchill Hospital and reflects on how we respond and learn from it. Dr Dollery is Deputy Medical Director at Oxford University Hospital NHS Foundation Trust and chairs the Trust’s Clinical Governance Committee which is a sub-committee of the Trust Management Executive. She has worked as a consultant cardiologist since 2003.

Care.data, the scheme to build an enormous database containing the medical records of all English patients has been scrapped. Dr Mark Porter investigates the fall-out following the cancellation of this expensive programme, which foundered on concerns about confidentiality and public and professional trust. Chair of the national EMIS user group and Sheffield GP Dr Geoff Schrecker and GP Dr Margaret McCartney discuss the scale of the failure of the care.data programme and outline what needs to happen in the future if valuable patient data is to be used for the public good. Twelve hundred adults and children die every year in the UK from asthma attacks, and these grim statistics have remained stubbornly consistent for decades. But there is light on the horizon as researchers in the field begin to stratify the disease; identifying patients with different types of asthma and treating them accordingly. Mark visits the Churchill Hospital in Oxford where some pioneering work has taken place to develop new diagnostic tests and new treatments. Ian Pavord, Professor of Respiratory Medicine at the Nuffield Department of Medicine, shows Mark the new FENO breath test for nitric oxide to test inflammation - soon to be available for use in general practice. Acne Rosacea is a debilitating and painful condition. It's characterised by redness, spots and inflammation on the face and affects both sexes but mainly women. Dr Bav Shergill of the British Association of Dermatologists discusses latest treatments. And the first in a new series dedicated to happy accidents that have altered modern medicine. First off, the pacemaker. Dr Margaret McCartney and Carl Heneghan, Professor of Evidence Based Medicine at the University of Oxford, tell the remarkable story of the serendipitous discovery of this life-saving device.

The Centre for Entrepreneurial Learning (CfEL) talked to Dr Helen Lee, Director of Research, Department of Haematology, University of Cambridge and Founder Diagnostics for the Real World about her very considerable experiences in diagnostics, founding companies, and the need to develop usable products for people in the developing world. Helen received her PhD from Cornell University and MSc from Oxford University. After post-doctoral training at Churchill Hospital in Oxford, the University of Geneva and St Louis Hospital in Paris, she began her career in diagnostics at the Centre National de Transfusion Sanguine in Paris where she was responsible for developing monoclonal blood typing reagents, the first widely used liquid blood typing reagents in Paris. Another major accomplishment of her group was one of the first monoclonal antibody based assays for hepatitis B surface antigen, which was subsequently licensed to the Pasteur Institute as the MONLISA HBsAg assay and is still on the market today. She then joined Abbott Laboratories to be responsible for Research & Development, and was promoted to General Manager of the Probe Diagnostics Business Unit where she managed over 100 people and an annual budget of >$20 million. She was also responsible for production of instruments as well as chemistry, marketing, quality and regulatory affairs of the product line. After leaving Abbott she founded a biotech company, Sentinel Biosciences Inc. in Palo Alto, CA, developing technologies for virus discovery. The company was successfully sold to one of the world's largest pharmaceutical companies. In 1996, she left industry for the University of Cambridge in order to focus on the development of technology and diagnostic assay for resource-poor settings. To commercialise the technologies developed at Cambridge, she founded the spin off company, Diagnostics for the Real World Ltd (DRW), in 2002. Awards: Dr Lee chaired the Diagnostic Steering Committee at the World Health Organization (WHO). She is the recipient of the 2005 Lord Lloyd Kilgerran Award, the 2006 British Female Inventor in Industry Award, the 2006 European Women of Achievement Award and the 2007 Asian Women of Achievement Award (presentation as pdf). The products and technologies developed by DDU scientists received the Medical Futures Innovation Award (UK) for its innovative sample collection device and more recently, the 2007 Tech Museum Innovation Award (US) for innovation in the Health Category, in recognition of the Signal Amplification technology, which greatly improves the sensitivity of rapid test for the detection of infectious diseases (see video interview) (hear audio interview). The unit has filed 12 families of patent applications, with 20 granted or allowed national patents, detailing inventions that improve the performance of rapid diagnostic test.

The Centre for Entrepreneurial Learning (CfEL) talked to Dr Helen Lee, Director of Research, Department of Haematology, University of Cambridge and Founder Diagnostics for the Real World about her very considerable experiences in diagnostics, founding companies, and the need to develop usable products for people in the developing world. Helen received her PhD from Cornell University and MSc from Oxford University. After post-doctoral training at Churchill Hospital in Oxford, the University of Geneva and St Louis Hospital in Paris, she began her career in diagnostics at the Centre National de Transfusion Sanguine in Paris where she was responsible for developing monoclonal blood typing reagents, the first widely used liquid blood typing reagents in Paris. Another major accomplishment of her group was one of the first monoclonal antibody based assays for hepatitis B surface antigen, which was subsequently licensed to the Pasteur Institute as the MONLISA HBsAg assay and is still on the market today. She then joined Abbott Laboratories to be responsible for Research & Development, and was promoted to General Manager of the Probe Diagnostics Business Unit where she managed over 100 people and an annual budget of >$20 million. She was also responsible for production of instruments as well as chemistry, marketing, quality and regulatory affairs of the product line. After leaving Abbott she founded a biotech company, Sentinel Biosciences Inc. in Palo Alto, CA, developing technologies for virus discovery. The company was successfully sold to one of the world's largest pharmaceutical companies. In 1996, she left industry for the University of Cambridge in order to focus on the development of technology and diagnostic assay for resource-poor settings. To commercialise the technologies developed at Cambridge, she founded the spin off company, Diagnostics for the Real World Ltd (DRW), in 2002. Awards: Dr Lee chaired the Diagnostic Steering Committee at the World Health Organization (WHO). She is the recipient of the 2005 Lord Lloyd Kilgerran Award, the 2006 British Female Inventor in Industry Award, the 2006 European Women of Achievement Award and the 2007 Asian Women of Achievement Award (presentation as pdf). The products and technologies developed by DDU scientists received the Medical Futures Innovation Award (UK) for its innovative sample collection device and more recently, the 2007 Tech Museum Innovation Award (US) for innovation in the Health Category, in recognition of the Signal Amplification technology, which greatly improves the sensitivity of rapid test for the detection of infectious diseases (see video interview) (hear audio interview). The unit has filed 12 families of patent applications, with 20 granted or allowed national patents, detailing inventions that improve the performance of rapid diagnostic test.

Dr Mark Porter goes on a weekly quest to demystify the health issues that perplex us. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, discusses with Mark new research that suggests that giving heart attack victims drugs to ease their chest pain could hamper the heart's ability to heal itself. The standard approach to appendicitis is to remove the inflamed organ. But a new review argues that antibiotics could be an alternative to surgery in some cases. Dileep Lobo, Professor of Gastrointestinal Surgery at the University of Nottingham, explains his team's findings. GP Margaret McCartney is on her soapbox about sick notes, following regulatory pressure from Europe that could allow people who fall ill on holiday getting compensatory time off work. Dr Kamran Abbasi, Editor of the Journal of the Royal Society of Medicine, looks into the evidence that the change from sick notes to fit notes two years ago has had an impact on people returning to work. Mark visits the pathology laboratories at St Thomas' Hospital in London to find out from Senior Biomedical Scientist Diane Murley how blood is analysed. And Dr Andrew Moore from the Pain Research Unit at the Churchill Hospital in Oxford talks about which over the counter painkillers are likely to work best for acute pain. Producer: Deborah Cohen.